Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antibody-drug conjugates
Manufacturing
Lonza bets big on US growth, snaps up Merck KGaA’s CDMO business
The addition of five manufacturing sites will more than double Lonza’s U.S. footprint and add 1,100 employees to the Swiss CDMO's U.S. roster.
Angus Liu
Nov 3, 2026 9:21am
Lonza upgrades plans for ADC expansion in Switzerland
Oct 29, 2026 10:12am
Fierce Biotech
After Enhertu: The slow hunt for next-gen HER2 breast cancer drugs
Oct 28, 2026 9:00am
Merck sees ‘pretty consistent’ data in sac-TMT’s 1st global ph. 3
Oct 26, 2026 11:30am
Bristol CMO touts more ph. 3 wins for bispecific ADC iza-bren
Oct 26, 2026 3:30am
Akeso CEO looks for more ivonescimab combos after AZ deal
Oct 25, 2026 11:30am
